Satellos Bioscience Inc. (MSLE)
NASDAQ: MSLE · Real-Time Price · USD
8.97
-0.11 (-1.21%)
At close: Sep 4, 2026, 4:00 PM EDT
9.11
+0.14 (1.56%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of $190.92 million as of September 4, 2026. Its market cap has increased by 126.21% in one year.
Market Cap
190.92M
Enterprise Value
127.45M
1-Year Change
126.21%
Ranking
Category
Stock Price
$8.97
ChartMarket Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from $45.99M to $190.92M, an increase of 315.11%. That is a compound annual growth rate of 32.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 190.92M | 113.81% |
| Dec 31, 2025 | 89.30M | -6.65% |
| Dec 31, 2024 | 95.65M | 160.46% |
| Dec 29, 2023 | 36.73M | 440.53% |
| Dec 30, 2022 | 6.79M | -73.94% |
| Dec 31, 2021 | 26.07M | -43.31% |
| Aug 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NovaBridge Biosciences | 208.80M |
| Oramed Pharmaceuticals | 208.40M |
| Alpha Cognition | 207.33M |
| Precision BioSciences | 206.18M |
| Cue Biopharma | 199.34M |
| Innate Pharma | 191.23M |
| LENZ Therapeutics | 187.27M |
| Canton Strategic Holdings | 181.67M |